Victory Square Stock Price, News & Analysis

Victory Square Technologies (OTC:VSQTF) reported Q1 2025 financial results, highlighting adjusted revenue of $6.528M and GAAP revenue of $4.540M with a gross margin of $1.504M. The company held $9.698M in cash and marketable securities as of March 31, 2025.

The company is strategically focusing on healthcare investments, notably through its 58% ownership in Hydreight Technologies, which operates a nationwide healthcare delivery platform with over 3,000 registered nurses. Other key portfolio companies include Insu Therapeutics (22.8% ownership), developing an oral insulin tablet, and Pawsible Ventures (49% ownership), targeting the pet wellness market.

Victory Square monetized non-core assets in Q1 2025, selling AI fintech solutions to Yocale.ai for approximately $880,000 in equity, following a previous sale of BlockX for $1.7 million in listed shares.

Victory Square Technologies (OTC:VSQTF), a venture builder focused on high-growth technology companies, reported strong financial results for 2024, with adjusted revenue of $23.0 million, up from $17.6 million in 2023. GAAP revenue increased 39% year-over-year to $16.7 million, with gross margins of $6.4 million.

The company's key portfolio company, Hydreight Technologies (TSXV:NURS), in which Victory Square holds a 64% stake, achieved $16.0 million in GAAP revenue (up 39% YoY) and expanded its network to over 3,000 registered nurses and 200+ prescribing physicians across all U.S. states.

Victory Square also highlighted its 22.8% ownership in Insu Therapeutics, a biotech company developing an oral insulin tablet for diabetes care. The company completed strategic initiatives including the sale of BlockX for $1.7 million and maintains a strong balance sheet with $6.16 million in cash and marketable securities.

Victory Square Technologies reported significant achievements for 2024 and outlined its 2025 strategic vision. The company achieved $10.7M in Q3 net income and reported an unaudited Net Asset Value of $127.5M as of January 28, 2025. Their subsidiary Hydreight Technologies ranked #56 on the 2024 Deloitte Technology Fast 500, achieved profitability, and launched a $10M Health Accelerator program.

The company's VSDHOne platform now powers healthcare brands across all 50 U.S. states, offering telehealth and compliance solutions. Key developments include Insu Therapeutics' work on oral insulin delivery technology, Stardust Solar's expansion into Houston with a $1.2M raise, and EdgeTI's advancement in quantum computing applications.

The company's portfolio has grown from $4M in 2017 to approximately $127M today, with investments totaling $13M across 25 companies selected from over 1,000 evaluated.

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) reported its Q2 2024 financial results. Revenue for the six-months ended June 30, 2024, was $7,993,311, a 46% increase compared to Q2 2023. The company's gross margin was $3,304,968, up from $2,541,910 in the comparative period. Victory Square is a Venture Builder with a portfolio of 25+ innovative companies across sectors including Digital Health, AI, Blockchain, and Climate Tech. The company's business model involves buying, building, and investing in early-stage tech companies, typically spending up to 48 months with them before spin-off or independence. Despite revenue growth, the company reported a net loss, primarily due to fair value write-downs on portfolio investments and operating losses from consolidated subsidiaries.

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) has announced that its wholly owned subsidiary, Block X Capital Corp. (BlockX), has entered into a merger agreement with Edge Total Intelligence Inc. (EdgeTI). The transaction involves EdgeTI acquiring all issued and outstanding shares of BlockX through a three-cornered amalgamation. Key points:

- EdgeTI will issue 4,250,000 subordinate voting shares (SVS) at $0.40 per share
- Total transaction value: $1,700,000
- A finder's fee of $85,000 will be paid in SVS at $0.43 per share
- Transaction closing is subject to TSXV approval and other conditions

BlockX focuses on blockchain, AI/ML, and cybersecurity solutions, while EdgeTI provides real-time digital operations software for situational awareness and accelerated action.

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) has announced that its portfolio company GameOn (CSE: GET) (OTCQB: GMETF) achieved record revenue of $1.85 million in Q1 2024, representing a 292% year-on-year increase. GameOn also reported a net income of $680,000, compared to a net loss of $390,000 in the same period last year.

Key highlights include:

• Partnership with Sportsology, receiving 59 million $GAME tokens
• Launch of the GameOn beta mobile app on Apple App Store and Google Play
• Record financial performance in 2023

GameOn CEO Matt Bailey emphasized the company's focus on driving fundamentals and delivering shareholder value, citing ongoing momentum from new league partnerships and the recent launch of $GAME on major exchanges.

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) announced that its portfolio company, XR Immersive Tech Inc. (CSE: VRAI), has entered into a $4.5 million licensing agreement with European company Deploy Reality. The agreement grants Deploy Reality rights to use XR Immersive Tech's location-based virtual reality (LBVR) platform for five years, starting July 1, 2024.

Key terms include an initial payment of $805,571.60 and monthly investments of $102,147 for R&D. Upon full payment, Deploy Reality will gain ownership of the SVR brand license. XR Immersive Tech's focus for H2 2024 includes expanding LBVR platform sales, developing AI applications, and enhancing VR/AR services in the enterprise sector.

Victory Square Technologies announced that its portfolio company, Hydreight Technologies, has partnered with a national laboratory to expand its at-home blood testing services across all 50 states by Q4 2024.

The expanded service will include tests for general wellness, nutrition, heart health, blood sugar, sexual health, thyroid, inflammation, and gut health.

Hydreight’s platform allows subscribers and nurses to administer tests at home, with results available through the app. The U.S. diagnostic testing market, valued at USD 84.85 billion in 2023, is expected to grow significantly, reaching USD 158.77 billion by 2033.

Victory Square's portfolio company, Hydreight, has shown significant growth in the home healthcare sector, reporting a 33% increase in Q1-2024 topline revenue, reaching $4.87 million. The company operates across all 50 US states, offering a mobile clinical network and at-home medical services. Hydreight has expanded its professional network to over 3,000 medical professionals and added 117 white-label locations nationwide. The company has also partnered with Ola Digital Health to provide health and wellness services in 300 independent retail pharmacies. Additionally, Hydreight launched VSDHOne for direct-to-consumer healthcare brands. The company plans to focus on profitability and further growth in 2024.